The increasing number of public genomic datasets and customer demand for integrated database have been driving Omicsoft's Land database development. In the past couple years, our flagship Land, OncoLand, has been an overwhelming success and is now being used by most of our pharma and biotech customers. Encouraged by our OncoLand success, we are in the process of bringing a series of DiseaseLand products to our customers, including ImmunoLand and CVMLand.
CVMLand, Cardiovascular and Metabolic Disease Land, is designed for diseases such as cardiovascular diseases, diabetes mellitus, glucose intolerance, islet autoantibody positive, lipid metabolism disorder and nutrition disorders. Currently it has more than 4000 samples with RNA-Seq and Expression data.
To keep up with the rapidly increasing number of public datasets, CVMLand updates every quarter. We are constantly looking, curating and processing new datasets. Given our customer-driven product development strategy, we welcome all our users and potential users to request their dataset of interest.
More more details, please check out our CVMLand webpage. Please feel free to register for a CVMLand trial on the webpage.
If you are interested in cardiovascular or metabolic disease genomic and clinical data, please contact us at email@example.com.